All Stories

  1. Naloxone Effects Against Cutaneous Leishmaniasis Caused by Leishmania major Strain MRHO/IR/75/ER in the BALB/c Mice
  2. Efficacy of intra-lesional injections of meglumine antimoniate once a week vs. twice a week in the treatment of cutaneous leishmaniasis caused by L. tropica in Iran: A randomized controlled clinical trial
  3. Novel nanodrugs for treatment of leishmaniasis.
  4. The role of MPL and imiquimod adjuvants in enhancement of immune response and protection in BALB/c mice immunized with soluble Leishmania antigen (SLA) encapsulated in nanoliposome
  5. The Need to Teach Vaccine Safety to Basic Scientists and Public Health Officials
  6. Therapeutic vaccines for leishmaniasis
  7. Micro/nanoparticle adjuvants for antileishmanial vaccines: Present and future trends